Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Fundamental Analysis of Venus Remedies (VENUSREM)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

You can now fully customise Watchlist by choosing any combination of your favorites Technical And Fundamental parameter.

Financial Highlights VENUSREM

EOD Close 48.20
Market Cap 57.67
EBITDA 27.37
Book Value 268.779
Profit margin -0.0461
Qtr Revenue Growth YOY 0.274
Qtr Earning Growth YOY 0
Revenue TTM 348.95
Gross Profit TTM 139.94
Revenue Per Share TTM 282.69
Face Value 10.00
Enterprise Value 18.84
Outstanding Shares 1.23
Consensus Target 0

Key Ratios of VENUSREM

Earning /Share -21.75
Diluted EPS TTM -13.03
PE Ratio 0
Div / Share 0
Div Yield % 0
PEG Ratio 0
Trailing PE 0
Forward PE 0
Price Sales TTM 0.188
Price Book MRQ 0.196
Enterprise Value / Revenue 8.42
Enterprise Value / EBITDA 0.688
Return on Asset TTM 0
Return on Equity TTM 0

Key Balance Sheet Fields

Period 31_Mar_2019 31-Mar-18 Growth
Common Stock 12.34 12.34 0 %
Current Liabilities 263.62 230.47 14.38 %
Total Liabilities 400.30 388.94 2.92 %
Current Assets 265.43 263.77 0.629 %
Total Assets 732.83 750.85 2.40 %
Working capital 1.81 33.30 94.56 %
Accounts Payable 36.00 29.33 22.74 %
Inventory 142.73 138.17 3.30 %
Net Receivable 38.04 47.27 19.53 %
   
   

Key Cash Flow Fields

Period 31_Mar_2019 31_Mar_2018 Growth
Cash EPS 0.438 0.254 72.44 %
Cash From Investment Activity -11.33 -11.48 1.31 %
Cash From Financial Activity -35.17 -39.23 10.35 %
Cash Operational Activity 45.33 31.19 45.34 %
Net Cash Flow -1.17 -19.52 94.01 %
NetIncome -28.57 -30.69 6.91 %
Capital Expenditure 9.92 14.10 29.65 %
Change To Inventory 0 0 � %
   
   



Annual Key Income Statement of VENUSREM

Period 31_Mar_2019 31_Mar_2018 Growth
Net Income From Continuing Ops -28.57 -30.69 6.91 %
Net Income -28.57 -30.69 6.91 %
Operating Income -1.45 5.76 125.17 %
Total Revenue 315.85 367.60 14.08 %
Operating Expense 317.30 361.84 12.31 %
Interest Expense 22.12 33.83 34.61 %
Tax Expense -1.15 3.16 136.39 %
Income Before tax -29.73 -27.53 7.99 %
Gross Profit 123.42 151.12 18.33 %
Dividend Paid 0 0 � %
   
   

Quarterly Key Income Statement of VENUSREM

Period 31_Dec_2019 30_Sep_2019 Growth
Net Income From Continuing Ops -0.962 0.416 331.25 %
Net Income -0.962 0.416 331.25 %
Operating Income 2.32 4.14 43.96 %
Total Revenue 96.86 87.89 10.21 %
Operating Expense 94.54 83.75 12.88 %
Interest Expense 4.07 4.91 17.11 %
Tax Expense 0.985 0.164 500.61 %
Income Before tax 0.0240 0.580 95.86 %
Gross Profit 41.75 40.79 2.35 %
Dividend Paid 0 0 � %
   
   




About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.